Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
484.00
8.8 (1.85%)
BSENSE

Dec 19

BSE+NSE Vol: 13.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "484.00",
    "chg": 8.8,
    "chgp": "1.85%",
    "dir": 1,
    "prev_price": "475.20",
    "mcapval": "962.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "13.29 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.466.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs4664-3758603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3758603.png",
        "date": "2025-12-15 10:08:18",
        "description": "Lincoln Pharmaceuticals has touched a new 52-week low of Rs.466.4, marking a significant decline in its stock price amid broader market movements and company-specific performance trends."
      },
      {
        "title": "Why is Lincoln Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharma-fallingrising-3756732",
        "imagepath": "",
        "date": "2025-12-12 00:44:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Underperformance Against Benchmarks</strong></p>\n<p>Lincoln Pharmaceuticals has been struggling to maintain momentum relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.76%, significantly underperforming the Sensex’s modest 0.52% fall. The one-month performance is even more stark, with the stock shedding 9.78% while the Sensex gained 1.13%. Year-to-date, the stock has plunged 40.23%, contrasting sharply with the Sensex’s 8.55% rise. Over the last year, Lincoln Pharma’s shares have halved, falling 50.02%, whereas the Sensex has managed a 4.04% gain. These figures underscore a persistent weakness in the stock’s price action, signalling challenges that have yet to be resolved.</p>\n<p><strong>Technical Indicators and Price Levels Signal Continued..."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.470.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-hits-52-week-low-amidst-continued-downtrend-3753444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3753444.png",
        "date": "2025-12-09 09:58:00",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.470.15, marking a significant decline amid a broader market downturn. The stock has experienced a sustained downward trend over the past four days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs481-3750766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3750766.png",
        "date": "2025-12-08 09:56:15",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex has shown mixed signals. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Stock Falls to 52-Week Low of Rs.481",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-stock-falls-to-52-week-low-of-rs481-3750772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LincolnPharmace_priceRelatedfactors_3750772.png",
        "date": "2025-12-08 09:55:52",
        "description": "Lincoln Pharmaceuticals has reached a new 52-week low of Rs.481, marking a significant decline in its stock price amid a broader market environment where the Sensex trades near its yearly highs. The stock has experienced a three-day consecutive fall, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharma. Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharma-upgraded-from-strong-sell-to-sell-by-marketsmojo-3737093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharma_mojoScore_3737093.png",
        "date": "2025-11-30 10:24:43",
        "description": "Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-bearish-signals-3719579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3719579.png",
        "date": "2025-11-21 08:02:34",
        "description": "Lincoln Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a nuanced market assessment for this Pharmaceuticals & Biotechnology sector stock."
      },
      {
        "title": "Is Lincoln Pharma. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lincoln-pharma-technically-bullish-or-bearish-3716849",
        "imagepath": "",
        "date": "2025-11-20 08:10:21",
        "description": "As of 19 November 2025, the technical trend for Lincoln Pharma has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The weekly MACD is mildly bullish, but the monthly MACD and KST are both bearish, indicating mixed signals. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a sideways trend on the weekly chart while being mildly bearish on the monthly. Additionally, the Dow Theory indicates a mildly bullish stance on the weekly but remains mildly bearish on the monthly. Overall, the strength of the bearish sentiment is supported by the monthly indicators, despite some positive movement in the weekly timeframe...."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-mixed-indicator-signals-3717038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3717038.png",
        "date": "2025-11-20 08:02:04",
        "description": "Lincoln Pharmaceuticals has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. Recent market data reveals a mild transition in trend dynamics, with key technical parameters signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 928,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.",
      "source": "BSE"
    },
    {
      "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Lincoln Pharma. falling/rising?

2025-12-12 00:44:15

Extended Underperformance Against Benchmarks

Lincoln Pharmaceuticals has been struggling to maintain momentum relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.76%, significantly underperforming the Sensex’s modest 0.52% fall. The one-month performance is even more stark, with the stock shedding 9.78% while the Sensex gained 1.13%. Year-to-date, the stock has plunged 40.23%, contrasting sharply with the Sensex’s 8.55% rise. Over the last year, Lincoln Pharma’s shares have halved, falling 50.02%, whereas the Sensex has managed a 4.04% gain. These figures underscore a persistent weakness in the stock’s price action, signalling challenges that have yet to be resolved.

Technical Indicators and Price Levels Signal Continued...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2025 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025

13-Nov-2025 | Source : BSE

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025

Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025

13-Nov-2025 | Source : BSE

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lincoln Pharmaceuticals Ltd has declared 18% dividend, ex-date: 12 Sep 25

stock-summary
SPLITS

Lincoln Pharmaceuticals Ltd has announced 10:2 stock split, ex-date: 19 Mar 09

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available